News
A potential new therapeutic target for Ewing sarcoma
The Oncobell sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most frequent bone cancer in children and adolescents, and a tumor known by its aggressiveness and tendency to metastasize. The research, published in International Journal of Cancer, has […]
IDIBELL obtains the TECNIO certification as a public technology facilitator
The IDIBELL Business development and Innovation area, led by Raquel Egea, has obtained the TECNIO certification as a “Public Technology Facilitator”. TECNIO is the seal granted by the Generalitat de Catalunya through ACCIÓ to identify Catalan differential technology, the providers that offer it and the facilitators involved in the process of technology and knowledge transfer, […]
The IDIBELL PhD Day grows stronger in its third edition
Last Friday, March 16th, the third edition of IDIBELL PhD Day took place at Duran i Reynals Hospital. This scientific symposium, organized by the predoctoral researchers of the Bellvitge Campus, aims to promote the research carried out by this researchers and encourage collaborations among the research groups they belong to. This year, approximately 150 people […]
Creation of a web platform for the identification of fronto-subcortical connectivity alterations in brain disorders
Researchers Oren Contreras-Rodríguez and Carlos Soriano-Mas, from the Psychiatry and Mental Health research group of the Neurosciences program of the Bellvitge Biomedical Research Institute (IDIBELL), have been awarded a Llavor grant from the Knowledge Industry Program of the Secretaria d’Universitats i Recerca del Departament d’Empresa i Coneixement of the Generalitat of Catalonia to carry out a project […]
IDIBELL’s researcher Manel Esteller is the most cited Spain-based biomedical scientist
Manel Esteller, head of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA researcher and professor of genetics at the University of Barcelona, is the biomedical scientist with projects in Spain most cited by other scientists, according to the latest edition of the Webometrics classification, published on February 26th by the cybermetrics group of the […]
Dr. Manel Esteller, Award for Innovation in the Healthcare Field in Oncology
Manel Esteller, Director of the Epigenetics and Cancer Biology Program at IDIBELL, ICREA Researcher and Professor of Genetics at the University of Barcelona, is the recipient of the Innovation Award in the Healthcare Field in Oncology, awarded by the Celgene Chair of Innovation in Health and the University of Alcalá. The award was given yesterday […]
ICABELL, a new boost to the internationalization of IDIBELL’s research
The Bellvitge Biomedical Research Institute has been awarded 176,734€ in order to carry out the “ICABELL – Internationalization of biomedical research on the Bellvitge Campus” project, whose main researcher is Dr. Josep Manuel Menchón. The aid is part of the Call for Boosting Actions: Europe Networks and Managers – Europe Technology Centers 2017, which is […]
Nobel Laureate Erwin Neher visits IDIBELL
The winner of the 1991 Nobel Prize for Medicine visits the institute and talks to its younger researchers Last Wednesday, February 21st, the Bellvitge Biomedical Research Institute (IDIBELL) welcomed professor Erwin Neher, Nobel Prize in Physiology or Medicine in 1991, to participate in an informal meeting with the pre and postdoctoral researchers of the institute. […]
RAC1 protein could be a new therapeutic target to fight neurodegeneration in Parkinson’s disease
A new research study reveals RAC1 protein could be a new therapeutic target to study the molecular mechanisms related to the neurodegenerative processes in Parkinson’s disease. The study, published in the online edition of the journal Molecular Neurobiology, is led by Antonella Consiglio, researcher at the Faculty of Medicine and Health Sciences of the University of Barcelona, the […]